Relationship and susceptibility profile of Staphylococcus aureus infection diabetic foot ulcers with Staphylococcus aureus nasal carriage

Foot

Volumn 23, Issue 1, 2013, Pages 11-16

  Taha, Aza Bahadeen ^a  

^a HAWLER MEDICAL UNIVERSITY   (Iraq)

Author keywords

Diabetic foot; Infection; Iraq; MRSA; Nasal carriage; Staphylococcus aureus

Indexed keywords

AMIKACIN; AMPICILLIN; CEFOTAXIME; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; FUSIDIC ACID; LEVOFLOXACIN; RIFAMPICIN; TETRACYCLINE;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CARRIER; BACTERIUM ISOLATION; CONTROLLED STUDY; DIABETIC FOOT; DIABETIC FOOT INFECTION; FEMALE; FOOT DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; NONHUMAN; NOSE SMEAR; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ADULT; AGED; ANTI-BACTERIAL AGENTS; CARRIER STATE; DIABETIC FOOT; FEMALE; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NOSE; OFLOXACIN; RIFAMPIN; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS;

EID: 84875381150     PISSN: 09582592     EISSN: 15322963     Source Type: Journal    
DOI: 10.1016/j.foot.2012.10.003     Document Type: Article

References (46)

1. Kutlu S.S., Cevahir N., Akalin S., Akin F., Caylak S.D., Bastemir M., et al. Prevalence and risk factors for methicillin-resistant Staphylococcus aureus colonization in a diabetic outpatient population: a prospective cohort study. American Journal of Infection Control 2012, 40(4):365-368.
2. Farzana K., Rashid Z., Akhtar N., Sattar A., Khan J.A., Nasir B. Nasal carriage of staphylococci in health care workers: antimicrobial susceptibility profile. Pakistan Journal of Pharmaceutical Sciences 2008, 21(3):290-294.
3. Wertheim H.F., Melles D.C., Vos M.C., van Leeuwen W., van Belkum A., Verbrugh H.A., et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infectious Diseases 2005, 5:751-762.
4. Weidenmaier C., Goerke C., Wolz C. Staphylococcus aureus determinants for nasal colonization. Trends in Microbiology 2012, 20(5):243-250.
5. Lozano C., G'mez-Sanz E., Benito D., Aspiroz C., Zarazaga M., Torres C. Staphylococcus aureus nasal carriage, virulence traits, antibiotic resistance mechanisms, and genetic lineages in healthy humans in Spain, with detection of CC398 and CC97 strains. International Journal of Medical Microbiology 2011, 301:500-505.
6. Seybold U., Schubert S., Bogner J.R., Hogardt M. Staphylococcus aureus infection following nasal colonization: an approach to rapid risk stratification in a university healthcare system. Journal of Hospital Infection 2011, 79:297-301.
7. Lipsky B.A., Berendt A.R., Deery H.G., Embil J.M., Joseph W.S., Karchmer A.W., et al. Diagnosis and treatment of diabetic foot infections. Clinical Infectious Diseases 2004, 39:885-910.
8. Mendes J.J., Marques-Costa A., Vilela C., Neves J., Candeias N., Cavaco-Silva P. Clinical and bacteriological survey of diabetic foot infections in Lisbon. Diabetes Research and Clinical Practice 2012, 95:153-161.
9. Melles D.C., Pauw E., Boogaard L., Boelens H.A., Peters J., Peeters J.K., et al. Host-microbe interplay in persistent Staphylococcus aureus nasal carriage in HIV patients. Microbes and Infection 2008, 10:151-158.
10. Ruhe J.J., Guzman L., Moss M., Riley W., Mildvan D., Perlman D.C., et al. Methicillin-susceptible Staphylococcus aureus nasal colonization and the risk of subsequent methicillin-resistant Staphylococcus aureus infections among hospitalized patients. Diagnostic Microbiology and Infectious Disease 2011, 71:163-166.
11. Pathak A., Marothi Y., Iyer R.V., Singh B., Sharma M., Eriksson B., et al. Nasal carriage and antimicrobial susceptibility of Staphylococcus aureus in healthy preschool children in Ujjain, India. BMC Pediatrics 2010, 10:100.
12. Harbarth S., Hawkey P.M., Tenover F., Stefani S., Pantosti A., Struelens M.J. Update on screening and clinical diagnosis of methicillin-resistant Staphylococcus aureus (MRSA). International Journal of Antimicrobial Agents 2011, 37:110-117.
13. Haamann F., Dulon D., Nienhaus A. MRSA as an occupational disease: a case series. International Archives of Occupational and Environmental Health 2011, 84:259-266.
14. Ako-Nai A.K., Ikemb I.C., Akinloye O.O., Aboderin A.O., Ikemd R.T., Kassim O.O. Characterization of bacterial isolates from diabetic foot infections in Ile-Ife Southwestern Nigeria. The Foot 2006, 16:158-164.
15. Turner J.M., Hakeem L.M., Lockman K.A., Bhattacharyya D.B., Campbell I.W. Diabetic MRSA foot infection - role of linezolid therapy. British Journal of Diabetes & Vascular Disease 2004, 4:44-46.
16. Zubair M., Malik A., Ahmad J. Clinico-microbiological study and antimicrobial drug resistance profile of diabetic foot infections in North India. The Foot 2011, 21:6-14.
17. Leung P.C. Diabetic foot ulcers - a comprehensive review. Surgeon 2007, 5(4):219-231.
18. Hokkam E.N. Assessment of risk factors in diabetic foot ulceration and their impact on the outcome of the disease. Primary Care Diabetes 2009, 3:219-224.
19. Mutluoglu M., Uzun G., Turhan V., Gorenek L., Ay H., Lipsky B.A. How reliable are cultures of specimens from superficial swabs compared with those of deep tissue in patients with diabetic foot ulcers?. Journal of Diabetes and Its Complications 2012, 26:225-229.
20. Sotto A., Richard J.L., Combescure C., Jourdan N., Schuldiner S., Bouziges N., et al. Beneficial effects of implementing guidelines on microbiology and costs of infected diabetic foot ulcers. Diabetologia 2010, 53:2249-2255.
21. Abdulrazak A., Bitar Z.I., Al-Shamali A.A., Mobasher L.A. Bacteriological study of diabetic foot infections. Journal of Diabetes and Its Complications 2005, 19:138-141.
22. Coia J.E., Duckworth G.J., Edwards D.I., Farrington M., Fry C., Humphreys H., et al. Guidelines for the control and prevention of methicillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. Journal of Hospital Infection 2006, 63S:S1-S44.
23. Richard J.L., Sotto A., Jourdan N., Combescure C., Vannereau D., Rodier M., et al. Risk factors and healing impact of multidrug-resistant bacteria in diabetic foot ulcers. Diabetes and Metabolism 2008, 34:363-369.
24. Schleyer A.M., Jarman K.M., Pharm D., Chan J.D., Dellit T.H. Role of nasal methicillin-resistant Staphylococcus aureus screening in the management of skin and soft tissue infections. American Journal of Infection Control 2010, 38:657-659.
25. Green B.N., Johnson C.D., Egan J.T., Rosenthal M., Griffith E.A., Evans M.W. Methicillin-resistant Staphylococcus aureus: an overview for manual therapists. Journal of Chiropractic Medicine 2012, 11:64-76.
26. Leski T., Tomasz A. Role of penicillin-binding protein 2 (PBP2) in the antibiotic susceptibility and cell wall cross-linking of Staphylococcus aureus: evidence for the cooperative functioning of PBP2 PBP4, and PBP2A. Journal of Bacteriology 2005, 187(5):1815-1824.
27. Taha A.B., Al-Salihi S.M.S. Antibiotic resistance of community and hospital acquired methicillin-resistant Staphylococcus aureus isolates from clinical specimens. American Medical Journal 2011, 2(2):65-71.
28. Safdar N., Bradley E.A. The risk of infection after nasal colonization with Staphylococcus aureus. American Journal of Medicine 2008, 121(4):310-315.
29. Tacconelli E. Screening and isolation for infection control. Journal of Hospital Infection 2009, 73:371-377.
30. Muňoz P., Hortal J., Giannella M., Barrio J.M., Rodríguez-Créixems M., Pérez M.J. Nasal carriage of S. aureus increases the risk of surgical site infection after major heart surgery. Journal of Hospital Infection 2008, 68:25-31.
31. Askarian M., Zeinalzadeh A., Japoni A., Alborzi A., Memish Z.A. Prevalence of nasal carriage of methicillin-resistant Staphylococcus aureus and its antibiotic susceptibility pattern in healthcare workers at Namazi Hospital, Shiraz, Iran. International Journal of Infectious Diseases 2009, 13:e241-e247.
32. Harrison L.S. Staphylococci. Textbook of diagnostic microbiology 2007, 367-407. Elsevier, Philadelphia. 3rd ed. C.R. Mahon, D.C. Lehman, G. Manuselis (Eds.).
33. Brown D.F., Edwards D.I., Hawkey P.M., Morrison D., Ridgway G.L., Towner K.J., et al. Guidelines for the laboratory diagnosis and susceptibility testing of methicillin-resistant Staphylococcus aureus (MRSA). Journal of Antimicrobial Chemotherapy 2005, 56:1000-1018.
34. Mohanasoundaram K.M., Lalitha M.K. Comparison of phenotypic versus genotypic methods in the detection of methicillin resistance in Staphylococcus aureus. Indian Journal of Medical Research 2008, 127:78-84.
35. European Committee for Antimicrobial Susceptibility Testing of the European Society of Clinical Microbiology and Infectious Diseases Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by agar dilution. Clinical Microbiology and Infection 2001, 6(9):509-515.
36. European Committee on Antimicrobial Susceptibility Testing Breakpoint tables for interpretation of MICs and zone diameters. Version 1.3 2011, http://www.eucast.org/.
37. British Society for Antimicrobial Chemotherapy BSAC methods for antimicrobial susceptibility testing. Version 10.2 2011, http://www.bsac.org.uk/.
38. Ahmed A.A., Elsharief E., Alsharief A. The diabetic foot in the Arab world. Journal of Diabetic Foot Complications 2011, 3(3):55-61.
39. Taha A.B. Nasal carriage of Staphylococcus aureus among the community population and hospital staff in Erbil, Iraq. MEJIM 2011, 4(2):16-20.
40. Costelloe C., Lovering A., Montgomery A., Lewis D., McNulty C., Hay A.D. Effect of antibiotic prescribing in primary care on methicillin-resistant Staphylococcus aureus carriage in community-resident adults: a controlled observational study. International Journal of Antimicrobial Agents 2012, 39:135-141.
41. Al Benwan K., Al Mulla A., Rotimi V.O. A study of the microbiology of diabetic foot infections in a teaching hospital in Kuwait. Journal of Infection and Public Health 2012, 5:1-8.
42. Zubair M., Malik A., Ahmad J. Incidence, risk factors for amputation among patients with diabetic foot ulcer in a North Indian tertiary care hospital. The Foot 2012, 22:24-30.
43. Huang Y., Chen C. Community-associated methicillin-resistant Staphylococcus aureus in children in Taiwan, 2000s. International Journal of Antimicrobial Agents 2011, 38:2-8.
44. Skov R., Christiansen K., Dancer S.J., Daum R.S., Dryden M., Huang Y., et al. Update on the prevention and control of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA). International Journal of Antimicrobial Agents 2012, 39:193-200.
45. Fadeyi A., Bolaji B.O., Oyedepo O.O., Adesiyun O.O., Adeboye M.A.N., Olanrewaju T.O., et al. Methicillin resistant Staphylococcus aureus carriage amongst healthcare workers of the critical care units in a Nigerian hospital. American Journal of Infectious Diseases 2010, 6(1):18-23.
46. Resch A., Wilke M., Fink C. The cost of resistance: incremental cost of methicillin-resistant Staphylococcus aureus (MRSA) in German hospitals. European Journal of Health Economics 2009, 10:287-297.